A5023334743- Head and Neck Cancer Studies
- Salivary Gland Tumors Diagnosis and Treatment
- Ear and Head Tumors
- Head and Neck Surgical Oncology
- Tracheal and airway disorders
- Oral and Maxillofacial Pathology
- Reconstructive Surgery and Microvascular Techniques
- Facial Nerve Paralysis Treatment and Research
- Tumors and Oncological Cases
- Voice and Speech Disorders
- Cancer Diagnosis and Treatment
- Dysphagia Assessment and Management
- Bone Tumor Diagnosis and Treatments
- Airway Management and Intubation Techniques
- Reconstructive Facial Surgery Techniques
- Lung Cancer Research Studies
- Organ and Tissue Transplantation Research
- Sinusitis and nasal conditions
- Oral health in cancer treatment
- COVID-19 and healthcare impacts
- Facial Rejuvenation and Surgery Techniques
- Esophageal and GI Pathology
- Colorectal and Anal Carcinomas
- Facial Trauma and Fracture Management
- Clinical practice guidelines implementation
Sorbonne Université
2016-2025
Hôpital Tenon
2016-2025
Assistance Publique – Hôpitaux de Paris
2016-2025
Hôpital Foch
2001-2024
Université Sorbonne Nouvelle
2022-2024
Hospices Civils de Lyon
2018-2024
Université Claude Bernard Lyon 1
2024
Sorbonne University Abu Dhabi
2023
Université Paris 1 Panthéon-Sorbonne
2023
Pitié-Salpêtrière Hospital
2020-2023
Abstract Heterogeneity can be a major component of meta‐analyses and by virtue that fact warrants investigation. Classic analysis methods, such as meta‐regression, are used to explore the sources heterogeneity. However, it may difficult apply method in complex cases or absence an priori hypothesis. This paper presents graphical identify trials, groups trials patients The contribution these overall result also evaluated with this method. Each trial is represented dot on 2D graph. X ‐axis...
•This ESMO–EURACAN Clinical Practice Guideline provides key recommendations for managing salivary gland cancer.•The guideline covers clinical and pathological diagnosis, staging risk assessment, treatment follow-up.•Treatment algorithms parotid, submandibular, sublingual minor cancer are provided.•The author group encompasses a multidisciplinary of experts from different institutions countries in Europe.•Recommendations based on available scientific data the authors' collective expert...
Sinonasal undifferentiated carcinoma (SNUC) is a very rare entity with poor prognosis. Due to the lack of studies on subject, evidence lacking concerning its management.A multicenter collaborative study was conducted assess treatment strategy, oncological outcome, and prognostic factors.Definitive analyses focused 54 patients majority advanced stage; 3-year overall survival (OS) recurrence-free (RFS) rates were, respectively, 62.4% 47.8%. During follow-up, 18 (33.3%) died, 10 (18.5%)...